Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cells ; 9(8)2020 07 30.
Artigo em Inglês | MEDLINE | ID: mdl-32751549

RESUMO

In addition to antigen presentation to CD4+ T cells, aggregation of cell surface major histocompatibility complex class II (MHC-II) molecules induces signal transduction in antigen presenting cells that regulate cellular functions. We previously reported that crosslinking of MHC-II induced the endocytosis of MHC-II, which was associated with decreased surface expression levels in murine dendritic cells (DCs) and resulted in impaired activation of CD4+ T cells. However, the downstream signal that induces MHC-II endocytosis remains to be elucidated. In this study, we found that the crosslinking of MHC-II induced intracellular Ca2+ mobilization, which was necessary for crosslinking-induced MHC-II endocytosis. We also found that these events were suppressed by inhibitors of Syk and phospholipase C (PLC). Treatments with a phorbol ester promoted MHC-II endocytosis, whereas inhibitors of protein kinase C (PKC) suppressed crosslinking-induced endocytosis of MHC-II. These results suggest that PKC could be involved in this process. Furthermore, crosslinking-induced MHC-II endocytosis was suppressed by inhibitors of clathrin-dependent endocytosis. Our results indicate that the crosslinking of MHC-II could stimulate Ca2+ mobilization and induce the clathrin-dependent endocytosis of MHC-II in murine DCs.


Assuntos
Clatrina/metabolismo , Células Dendríticas/imunologia , Endocitose/efeitos dos fármacos , Antígenos de Histocompatibilidade Classe II/metabolismo , Proteína Quinase C/metabolismo , Animais , Apresentação de Antígeno/imunologia , Células da Medula Óssea/citologia , Cálcio/metabolismo , Células Cultivadas , Clatrina/antagonistas & inibidores , Reagentes de Ligações Cruzadas/metabolismo , Endocitose/imunologia , Estrenos/farmacologia , Masculino , Camundongos , Ésteres de Forbol/farmacologia , Proteína Quinase C/antagonistas & inibidores , Pirrolidinonas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Organismos Livres de Patógenos Específicos , Estaurosporina/farmacologia , Estilbenos/farmacologia , Quinase Syk/antagonistas & inibidores , Quinase Syk/metabolismo , Fosfolipases Tipo C/antagonistas & inibidores , Fosfolipases Tipo C/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA